Prostate-Specific Antigen Levels and Prognosis in Patients with Hormone-Refractory Prostate Cancer Treated with Low-Dose Dexamethasone

Publisher： Karger

E-ISSN： 1423-0399|68|1|10-15

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.68, Iss.1, 2002-01, pp. : 10-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Palliative Treatment of Bone Metastases in Hormone-Refractory Prostate Cancer: Effects of Pamidronate on the Carboxyterminal Telopeptide of Type-I Collagen Level in Patients with Increasing Prostate-Specific Antigen Levels

By  

Urologia Internationalis, Vol. 78, Iss. 4, 2007-05 ,pp. : 345-350

Karger

Access to resources Recommend Favorite

The relationship between prostate‐specific antigen and TNM classification or Gleason score in prostate cancer patients with low prostate‐specific antigen levels

By  

THE PROSTATE, Vol. 75, Iss. 10, 2015-07 ,pp. : 1034-1042

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase II Study of Repeated Single 24-Hour Infusion of Low-Dose 5-Fluorouracil for Palliation in Symptomatic Hormone-Refractory Prostate Cancer

By  

Urologia Internationalis, Vol. 69, Iss. 4, 2002-11 ,pp. : 273-277

Karger

Access to resources Recommend Favorite

Patients with Low Prostate-Specific Antigen Levels (≤4 ng/ml) Would Benefit from a Twelve-Core Biopsy Protocol for Prostate Cancer Detection

By  

Urologia Internationalis, Vol. 78, Iss. 4, 2007-05 ,pp. : 318-322

Karger

Access to resources Recommend Favorite

Prostate Cancer Screening with Prostate-Specific Antigen in Hemodialysis Patients

By  

Urologia Internationalis, Vol. 78, Iss. 4, 2007-05 ,pp. : 334-337

Karger

Access to resources Recommend Favorite